These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9858596)

  • 1. The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation.
    Gao Q; Srinivasan S; Boyer SN; Wazer DE; Band V
    Mol Cell Biol; 1999 Jan; 19(1):733-44. PubMed ID: 9858596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells.
    Gao Q; Singh L; Kumar A; Srinivasan S; Wazer DE; Band V
    J Virol; 2001 May; 75(9):4459-66. PubMed ID: 11287601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.
    Gao Q; Kumar A; Singh L; Huibregtse JM; Beaudenon S; Srinivasan S; Wazer DE; Band H; Band V
    Cancer Res; 2002 Jun; 62(11):3315-21. PubMed ID: 12036950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKN binds and phosphorylates human papillomavirus E6 oncoprotein.
    Gao Q; Kumar A; Srinivasan S; Singh L; Mukai H; Ono Y; Wazer DE; Band V
    J Biol Chem; 2000 May; 275(20):14824-30. PubMed ID: 10809724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high-risk human papillomavirus type 16 E6 counters the GAP function of E6TP1 toward small Rap G proteins.
    Singh L; Gao Q; Kumar A; Gotoh T; Wazer DE; Band H; Feig LA; Band V
    J Virol; 2003 Jan; 77(2):1614-20. PubMed ID: 12502878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells.
    Dalal S; Gao Q; Androphy EJ; Band V
    J Virol; 1996 Feb; 70(2):683-8. PubMed ID: 8551603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells.
    Liu Y; Chen JJ; Gao Q; Dalal S; Hong Y; Mansur CP; Band V; Androphy EJ
    J Virol; 1999 Sep; 73(9):7297-307. PubMed ID: 10438818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.
    Kumar A; Zhao Y; Meng G; Zeng M; Srinivasan S; Delmolino LM; Gao Q; Dimri G; Weber GF; Wazer DE; Band H; Band V
    Mol Cell Biol; 2002 Aug; 22(16):5801-12. PubMed ID: 12138191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.
    DeWeese TL; Walsh JC; Dillehay LE; Kessis TD; Hedrick L; Cho KR; Nelson WG
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):145-54. PubMed ID: 9054890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the roles of E6 binding to E6TP1 and nuclear localization in the human papillomavirus type 31 life cycle.
    Lee C; Wooldridge TR; Laimins LA
    Virology; 2007 Feb; 358(1):201-10. PubMed ID: 16999984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
    Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
    Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hAda3 degradation by papillomavirus type 16 E6 correlates with abrogation of the p14ARF-p53 pathway and efficient immortalization of human mammary epithelial cells.
    Shamanin VA; Sekaric P; Androphy EJ
    J Virol; 2008 Apr; 82(8):3912-20. PubMed ID: 18256148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.
    Crook T; Tidy JA; Vousden KH
    Cell; 1991 Nov; 67(3):547-56. PubMed ID: 1657399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
    Scheffner M; Werness BA; Huibregtse JM; Levine AJ; Howley PM
    Cell; 1990 Dec; 63(6):1129-36. PubMed ID: 2175676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of functional, stable, unmutated recombinant human papillomavirus E6 oncoprotein: implications for HPV-tumor diagnosis and therapy.
    Illiano E; Demurtas OC; Massa S; Di Bonito P; Consalvi V; Chiaraluce R; Zanotto C; De Giuli Morghen C; Radaelli A; Venuti A; Franconi R
    J Transl Med; 2016 Jul; 14(1):224. PubMed ID: 27465494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
    Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins.
    Scheffner M; Takahashi T; Huibregtse JM; Minna JD; Howley PM
    J Virol; 1992 Aug; 66(8):5100-5. PubMed ID: 1321290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
    Harden ME; Prasad N; Griffiths A; Munger K
    mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.
    Sedman SA; Hubbert NL; Vass WC; Lowy DR; Schiller JT
    J Virol; 1992 Jul; 66(7):4201-8. PubMed ID: 1318401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.